ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	CTRI
Last refreshed on:	24 November 2021
Main ID:	CTRI/2014/12/005252
Date of registration:	04-12-2014
Prospective Registration:	No
Primary sponsor:	FATHER MULLER MEDICAL COLLEGE
Public title:	Bacteria isolated from acne and their sensitivity and resistance to topical agents and oral antibiotics in vitro.
Scientific title:	Sensitivity and resistance pattern of Propionibacterium acnes for topical agents and oral antibiotics in acne vulgaris:an in vitro study - AV
Date of first enrolment:	01-09-2013
Target sample size:	50
Recruitment status:	Open to Recruitment
URL:	http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=9413
Study type:	Observational
Study design:	Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Phase:	N/A

Countries of recruitment
India

Contacts

Name:	DR RAMESH BHAT M
Address:	DEPT. OF DERMATOLOGY FATHER MULLER MEDICAL COLLEGE KANKANADY MANGALORE 35,O.P.D OF DERMATOLOGY FATHER MULLER MEDICAL COLLEGE KANKANADY MANGALORE-575002 575002 Dakshina Kannada, KARNATAKA India
Telephone:	9845084224
Email:	rameshderma@gmail.com
Affiliation:	FATHER MULLER MEDICAL COLLEGE

Name:	DR RAMESH BHAT M
Address:	DEPT. OF DERMATOLOGY FATHER MULLER MEDICAL COLLEGE KANKANADY MANGALORE 35,O.P.D OF DERMATOLOGY Father muller medical college Kankanady Mangalore-575002 575002 Dakshina Kannada, KARNATAKA India
Telephone:	9845084224
Email:	rameshderma@gmail.com
Affiliation:	FATHER MULLER MEDICAL COLLEGE

Key inclusion & exclusion criteria

Inclusion criteria: AGE ABOVE 12 YEARS & OF BOTH SEXES.

PATIENTS WITH MODERATE TO SEVERE ACNE VULGARIS.

PATIENT WILLING FOR THE REQUIRED INVESTIGATION WITH A WRITTEN AND INFORMED CONSENT AND ASSENT(WHEREVER NECESSARY).
Exclusion criteria: AGE LESS THAN 12 YEARS.

PATIENTS NOT WILLING FOR NECESSARY INVESTIGATIONS.

Age minimum:
Age maximum:
Gender:

Health Condition(s) or Problem(s) studied

Health Condition 1: null- Any patient diagnosed to have moderate to severe acne vulgaris willing to give pus from the acne lesions will be enrolled into the study after taking informed consent/assent.

Intervention(s)

Primary Outcome(s)

PUS OR COMEDONE EXPRESSED MATERIAL IS TAKEN AND CULTURED IN PROPIONIBACTERIUM SPECIFIC MEDIA.Timepoint: 3-7DAYS

Secondary Outcome(s)

ONCE PROPIONIBACTERIUM ACNES IS ISOLATED SPECIES IDENTIFICATION IS DONE BY VARIOUS BIOCHEMICAL TESTS AND SENSITIVITY AND RESISTANCE PATTERN AGAINST VARIOUS TOPICAL AND ORAL ANTIBIOTICS IS IDENTIFIED BY STANDARD DISC DIFFUSION METHODTimepoint: 2-3 WEEKS

Secondary ID(s)

NIL

Source(s) of Monetary Support

FATHER MULLER MEDICAL COLLEGE

Secondary Sponsor(s)

Ethics review

Status: Approved
Approval date: 07/08/2013
Contact:

FATHER MULLER INSTITUTIONAL ETHICS COMMITTEE

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.